Cargando…

CircGSAP alleviates pulmonary microvascular endothelial cells dysfunction in pulmonary hypertension via regulating miR-27a-3p/BMPR2 axis

BACKGROUND: Our previous study showed that circular RNA-gamma-secretase-activating protein (circGSAP) was down-regulated in pulmonary microvascular endothelial cells (PMECs) in response to hypoxia, and regulated the cell cycle of PMECs via miR-942-5p sponge in pulmonary hypertension (PH). However, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yuanyuan, Jiang, Rong, Hu, Xiaoyi, Gong, Sugang, Wang, Lan, Wu, Wenhui, Li, Jinling, Kang, Xinyang, Xia, Shijin, Liu, Jinming, Zhao, Qinhua, Yuan, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675109/ https://www.ncbi.nlm.nih.gov/pubmed/36403044 http://dx.doi.org/10.1186/s12931-022-02248-7

Ejemplares similares

CircGSAP regulates the cell cycle of pulmonary microvascular endothelial cells via the miR-942-5p sponge in pulmonary hypertension
por: Sun, Yuanyuan, et al.
Publicado: (2022)

circGSAP: A New Clinical Biomarker for Idiopathic Pulmonary Hypertension?
por: Sun, Xishi, et al.
Publicado: (2021)

The Impact of Abnormal Lipid Metabolism on the Occurrence Risk of Idiopathic Pulmonary Arterial Hypertension
por: Wei, Yaqin, et al.
Publicado: (2023)

The effect of docosahexaenoic acid on predicting the survival of patients with idiopathic pulmonary arterial hypertension
por: Huai, Xu, et al.
Publicado: (2021)

Prophylactic function of excellent compliance with LTOT in the development of pulmonary hypertension due to COPD with hypoxemia
por: Xiong, Wei, et al.
Publicado: (2018)

Soluble ST2 and mixed venous oxygen saturation for prediction of mortality in patients with pulmonary hypertension
por: Sun, Yuanyuan, et al.
Publicado: (2021)

A Generic Software Architecture for Prognostics (GSAP)
por: Teubert, Christopher, et al.
Publicado: (2017)

Acute vasoreactivity testing predicts outcome of idiopathic pulmonary arterial hypertension patients with a negative acute response
por: Sun, Yuanyuan, et al.
Publicado: (2020)

Role of miR‐21‐5p/FilGAP axis in estradiol alleviating the progression of monocrotaline‐induced pulmonary hypertension
por: Hu, Xiaoyi, et al.
Publicado: (2022)

Liver dysfunction in idiopathic pulmonary arterial hypertension: prevalence, characteristics and prognostic significance, a retrospective cohort study in China
por: Luo, Cijun, et al.
Publicado: (2021)

The Different Effects of Direct Bilirubin on Portopulmonary Hypertension and Idiopathic Pulmonary Arterial Hypertension
por: Li, Yuan, et al.
Publicado: (2022)

Dysregulated lncRNA TUG1 in different pulmonary artery cells under hypoxia
por: Lv, Zhenchun, et al.
Publicado: (2021)

GSAP regulates lipid homeostasis and mitochondrial function associated with Alzheimer’s disease
por: Xu, Peng, et al.
Publicado: (2021)

The predictive value of minute ventilation versus carbon dioxide production in pulmonary hypertension associated with left heart disease
por: Zhong, Xiujun, et al.
Publicado: (2021)

BMPR2 spruces up the endothelium in pulmonary hypertension
por: Xiong, Jianhua
Publicado: (2015)

GSAP modulates γ-secretase specificity by inducing conformational change in PS1
por: Wong, Eitan, et al.
Publicado: (2019)

Exercise Physiology and Pulmonary Hemodynamic Abnormality in PH Patients with Exercise Induced Venous-To-Systemic Shunt
por: Guo, Jian, et al.
Publicado: (2015)

Consequences of BMPR2 Deficiency in the Pulmonary Vasculature and Beyond: Contributions to Pulmonary Arterial Hypertension
por: Andruska, Adam, et al.
Publicado: (2018)

The genetics of pulmonary arterial hypertension in the post-BMPR2 era
por: Fessel, Joshua P., et al.
Publicado: (2011)

Cognitive Dysfunction in Patients with Pulmonary Hypertension
por: Yuan, Ping, et al.
Publicado: (2022)

Increased Levels of Runt-Related Transcription Factor 2 Are Associated With Poor Survival of Patients With Idiopathic Pulmonary Arterial Hypertension
por: Yuan, Xuntao, et al.
Publicado: (2020)

Impact of anaemia on lung function and exercise capacity in patients with stable severe chronic obstructive pulmonary disease
por: Guo, Jian, et al.
Publicado: (2015)

Molecular and functional characterization of the BMPR2 gene in Pulmonary Arterial Hypertension
por: Pousada, Guillermo, et al.
Publicado: (2017)

Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2
por: Novoyatleva, Tatyana, et al.
Publicado: (2021)

Pulmonary arterial hypertension drugs can partially restore altered angiogenic capacities in bmpr2‐silenced human lung microvascular endothelial cells
por: Tielemans, Birger, et al.
Publicado: (2023)

Pulmonary arterial hypertension preceding idiopathic pulmonary fibrosis in a BMPR2 mutation positive patient
por: Raamsteeboers, Aniek J., et al.
Publicado: (2014)

Exosomal circular RNAs: Biogenesis, effect, and application in cardiovascular diseases
por: Hu, Xiaoyi, et al.
Publicado: (2022)

Copy-number variation in BMPR2 is not associated with the pathogenesis of pulmonary arterial hypertension
por: Johnson, Jennifer A, et al.
Publicado: (2009)

A Novel BMPR2 Mutation Associated with Pulmonary Arterial Hypertension in an Octogenarian
por: Johri, Shilpa, et al.
Publicado: (2010)

Functional Changes in Pulmonary Arterial Endothelial Cells Associated with BMPR2 Mutations
por: Wang, Hu, et al.
Publicado: (2014)

Three novel BMPR2 mutations associated with advanced pulmonary arterial hypertension
por: Hara, Hironori, et al.
Publicado: (2017)

15 years journey of idiopathic pulmonary arterial hypertension with BMPR2 mutation
por: Ahn, Kyung Jin, et al.
Publicado: (2019)

Adverse effects of BMPR2 suppression in macrophages in animal models of pulmonary hypertension
por: West, James, et al.
Publicado: (2020)

Screening for pulmonary arterial hypertension in adults carrying a BMPR2 mutation
por: Montani, David, et al.
Publicado: (2021)

Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations
por: Pfarr, Nicole, et al.
Publicado: (2011)

Mutation in BMPR2 Promoter: A ‘Second Hit’ for Manifestation of Pulmonary Arterial Hypertension?
por: Viales, Rebecca Rodríguez, et al.
Publicado: (2015)

Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension
por: Long, Lu, et al.
Publicado: (2015)

BMPR2 Promoter Variants Effect Gene Expression in Pulmonary Arterial Hypertension Patients
por: Song, Jie, et al.
Publicado: (2020)

Structural consequences of BMPR2 kinase domain mutations causing pulmonary arterial hypertension
por: Chaikuad, Apirat, et al.
Publicado: (2019)

Author Correction: Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2
por: Novoyatleva, Tatyana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sbjalniuiu5eak2tghsf196hne